Linking 3D printing, machine learning, and robotics for high precision implants
Post-money valuation โ
$98.6M
As of Feb 2022 ยท from Monogram Orthopaedics Stock 2 ยท pre-money + amount raised, not a traded price
Total raised
$39,125,237
Across 5 rounds since 2019
Latest share price
$7.25
Reg A Offering (2022) offering price
Financials
FY2017โFY2024 ยท from SEC filings ยท hover any figure for its source
$0
โ$712K
2017
$0
โ$712K
2018
$0
โ$1.8M
2019
$0
โ$9.1M
2020
$628K
โ$11.8M
2021
$0
โ$13.7M
2022
$365K
โ$13.7M
2023
โ$16.3M
2024
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022 audited
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$0
$0
$0
$628,246
$0
$364,999
โ
Cost of goods sold
$0
$0
$0
$0
$458,675
$0
$17,633,028
โ
Gross margin
โ
โ
โ
โ
27%
โ
-4731%
โ
Net income
-$712,268
-$712,268
-$1,796,265
-$9,068,006
-$11,814,968
-$13,690,947
-$13,745,217
-$16,328,000
Taxes paid
โ
โ
โ
$0
$0
$0
$0
$0
Balance sheet
Cash
$922,108
$922,108
$2,319,393
$5,586,748
$5,535,710
$10,468,645
$13,589,028
$15,658,000
Accounts receivable
$0
$0
$0
$0
$0
$0
$364,999
โ
Total assets
$1,184,254
$1,184,254
$2,620,141
$8,115,888
$8,715,366
$13,690,063
$16,579,008
$17,770,000
Short-term debt
โ
โ
โ
$0
$0
$0
โ
โ
Long-term debt
$180,000
$223,000
$48,000
$0
$0
$0
$0
โ
Total liabilities
$2,575,280
$2,575,280
$2,894,773
$0
$5,911,236
$9,540,886
$3,181,942
$3,267,000
Other
Headcount
2
2
12
โ
23
27
28
โ
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.